US Announces Plans for Public Health Pathogen Genomics Centers of Excellence Biosurveillance July 14, 2021 …
Licensing Opportunity: Virus-Like Particle Technology for Universal Flu Vaccine Contracts + Grants July 13, 2021 …
NIAID to Create New Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Contracts + Grants July 13, 2021 …
Africa Malaria Task Force Reconvenes to Share Resources, Strategies and Expertise Biosecurity July 12, 2021 …
USAMRIID Scientists Continue Critical Work Against Select Agents While Aiding Pandemic Response Biosecurity July 4, 2021 …
New Manufacturing Plant Gives Canada Domestic Production Capability for N95-Type Mask Filters Industry News July 4, 2021 …
T Cells Primed Up From mRNA Vaccines Able to Recognize SARS-CoV-2 Variants of Concern Pathogens July 4, 2021 …
Patients with Alpha and Beta COVID-19 Variants Less Likely to Be Asymptomatic, Despite No Increase in Viral Load Pathogens June 23, 2021 …
RFI Supports Research on Impact of Nuclear Incident on the Microbiome and Development of Targeted Therapeutics CBRNE June 6, 2021 …
The Long Lasting Effect of Bubonic Plague on Human Immunity Genes Historical Reflections June 5, 2021 …
Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway Medical Countermeasures June 1, 2021 …
Johnson & Johnson COVID-19 Vaccinations Resume: Understanding Risks and Benefits Public Health April 26, 2021 …
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals Industry News April 15, 2021 …
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder Medical Countermeasures April 7, 2021 …
